As of 2024-12-14, the Intrinsic Value of Cardiol Therapeutics Inc (CRDL.TO) is
-2.21 CAD. This CRDL.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.93 CAD, the upside of Cardiol Therapeutics Inc is
-214.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.21 CAD
Intrinsic Value
CRDL.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-2.21 - -2.21 |
-2.21 |
-214.72% |
| P/E |
(3.22) - (4.57) |
(3.92) |
-303.1% |
| DDM - Stable |
(4.26) - 111.79 |
53.76 |
2685.6% |
| DDM - Multi |
(0.41) - 8.68 |
(0.88) |
-145.4% |
CRDL.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
157.49 |
| Beta |
2.91 |
| Outstanding shares (mil) |
81.60 |
| Enterprise Value (mil) |
141.78 |
| Market risk premium |
5.10% |
| Cost of Equity |
7.46% |
| Cost of Debt |
5.00% |
| WACC |
7.45% |